SCHEMBL31548024

SCHEMBL31548024

CCCCCCCCCc1ccccc1N(c1ccccc1CCCCCCCCC)c1ccccc1CCCCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.56
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
BID P55957 3/20 0.44
MCL1 Q07820 3/20 0.44
BCL2L1 Q07817 2/20 0.44
BAK1 Q16611 2/20 0.44
KAT8 Q9H7Z6 2/20 0.44
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
EP300 Q09472 1/20 0.44
KAT2A Q92830 1/20 0.44
KAT2B Q92831 1/20 0.44
KAT5 Q92993 1/20 0.44
SAE1 Q9UBE0 1/20 0.44
KCNH2 Q12809 2/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
ALOX5 P09917 2/20 0.42
PTGS2 P35354 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL9284697 0.93 LIPG (0.50) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL14839969 0.92 LIPG (0.46) LIPGNR1H2NR1H3ALOX5PTGS2
SCHEMBL7922788 0.91 LIPG (0.51) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL27910854 0.91 LIPG (0.51) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL31622303 0.91 LIPG (0.51) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL28160478 0.91 LIPG (0.51) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL28041959 0.89 LIPG (0.49) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL5424386 0.88 LIPG (0.56) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL5499862 0.88 LIPG (0.56) LIPGNR1H2NR1H3BIDMCL1
SCHEMBL5228295 0.88 LIPG (0.56) LIPGNR1H2NR1H3BIDMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4545621-A2 LUBRICANT COMPOSITIONS CONTAINING HIGH C9 DISUBSTITUTED DIPHENYLAMINE ANTIOXIDANT CONTENT Infineum International Limited (GB) 2025-04-30 EP claimed
WO-2026087620-A1 LUBRICANT COMPOSITIONS CONTAINING HIGH C9 DISUBSTITUTED DIPHENYLAMINE ANTIOXIDANT CONTENT INFINEUM INTERNATIONAL LIMITED (GB) 2026-04-30 WO disclosed
US-20260109910-A1 Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content INFINEUM INTERNATTIONAL LTD (GB) 2026-04-23 US disclosed
EP-4545621-A2 LUBRICANT COMPOSITIONS CONTAINING HIGH C9 DISUBSTITUTED DIPHENYLAMINE ANTIOXIDANT CONTENT Infineum International Limited (GB) 2025-04-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109910-A1 Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content C9, SOD1, TDO2 LIPG 1520/4885NR1H2 2767/4885NR1H3 2967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.